Trials / Terminated
TerminatedNCT00507702
Identification of Key Blood Molecular Markers for Immunotherapy
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 191 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To identify unique blood markers in cancer patients so that we can identify patients with evidence of pre-existing immunity who may be a responder to immunotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | phlebotomy | Standard of care |
Timeline
- Start date
- 2006-07-06
- Primary completion
- 2015-02-25
- Completion
- 2015-02-25
- First posted
- 2007-07-26
- Last updated
- 2019-04-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00507702. Inclusion in this directory is not an endorsement.